San‐Yang Chen,Hua‐Peng Zhang,Jie Li,Ji‐Hua Shi,Hong‐Wei Tang,Yi Zhang,Jia‐Kai Zhang,Pei‐Hao Wen,Zhi‐Hui Wang,Xiao‐Yi Shi,Yu‐Ting He,Bo‐Wen Hu,Han Yang,Wen‐Zhi Guo,Shui‐Jun Zhang
Abstract:<p>Hepatic ischemia‐reperfusion (I/R) injury, which mainly involves inflammatory responses and apoptosis, is a common cause of organ dysfunction in liver transplantation. As a critical mediator of inflammation and apoptosis in various cell types, the role of tripartite motif‐containing 27 (TRIM27) in hepatic I/R injury remains undetermined. This study systemically evaluated the putative role of TRIM27‐ TGF‐β–activated kinase 1 (TAK1)‐JNK/p38 signaling in hepatic I/R injury. TRIM27 expression was significantly downregulated in liver tissue from liver transplantation patients, mice subjected to hepatic I/R surgery and hepatocytes challenged by hypoxia/reoxygenation (H/R) treatment. Subsequently, using global <i>Trim27</i> knockout mice (<i>Trim27‐</i>KO mice) and hepatocyte‐specific <i>Trim27</i> transgenic mice (<i>Trim27‐</i>HTG mice), TRIM27 functions to ameliorate liver damage, reduce the inflammatory response and prevent cell apoptosis. In parallel <i>in vitro</i> studies, activating TRIM27 also prevented H/R‐induced hepatocyte inflammation and apoptosis. Mechanistically, TRIM27 constitutively interacted with the critical components TAK1 and TAK1 binding protein 2/3 (TAB2/3) and promoted the degradation of TAB2/3, leading to inactivation of TAK1 and the subsequent suppression of downstream JNK/p38 signaling. Conclusion: TRIM27 is a key regulator of hepatic I/R injury by mediating the degradation of TAB2/3 and the suppression of downstream TAK1‐JNK/p38 signaling. TRIM27 may be a promising approach to protect the liver against I/R‐mediated hepatocellular damage in transplant recipients.</p>
What problem does this paper attempt to address?
The problem that this paper attempts to solve is the specific role of TRIM27 in liver ischemia - reperfusion (I/R) injury and its mechanism. Specifically, the study aims to explore the protective role of TRIM27 in liver I/R injury and its mechanism of reducing the inflammatory response and apoptosis by inhibiting TAK1 activity.
### Research Background
Liver ischemia - reperfusion (I/R) injury is a common cause of organ dysfunction in liver transplantation, complex liver resection, hemorrhagic shock, and severe liver trauma surgery. This injury mainly involves the inflammatory response and apoptosis. Although the importance of liver I/R injury is recognized clinically, its mechanism has not been fully understood, and there are currently no effective interventions to prevent or treat this condition. Therefore, it is particularly urgent to find new treatment strategies to improve the outcome of liver transplantation.
### Research Objectives
1. **Determine the role of TRIM27 in liver I/R injury**: Study the expression changes of TRIM27 in liver I/R injury and its impact on liver injury.
2. **Explore the protective mechanism of TRIM27**: Reveal how TRIM27 reduces the inflammatory response and apoptosis by inhibiting TAK1 activity, thereby protecting the liver from I/R injury.
### Main Findings
1. **The decrease in TRIM27 expression is associated with liver I/R injury**:
- In liver transplantation patients and mouse models, the expression of TRIM27 decreased significantly after liver I/R injury.
- In vitro experiments, the expression of TRIM27 also decreased significantly in hepatocytes after hypoxia/reoxygenation (H/R) treatment.
2. **TRIM27 deficiency aggravates liver injury and the inflammatory response**:
- In Trim27 - KO mice after liver I/R injury, the serum ALT and AST levels increased significantly, and liver tissue pathological examination showed a larger necrotic area.
- TRIM27 deficiency led to more CD11b - positive inflammatory cell infiltration, and the mRNA levels of pro - inflammatory factors (such as TNF - α, IL - 6, IL - 1β, CCL2, and CXCL2) increased significantly.
- The NF - κB signaling pathway was further activated in TRIM27 - deficient mice.
3. **TRIM27 deficiency exacerbates apoptosis**:
- In the liver tissue of TRIM27 - deficient mice, the number of apoptotic cells increased significantly, the expression of Bcl2 decreased, while the expressions of Bad and Bax increased.
- In vitro experiments, in hepatocytes with TRIM27 knockdown, after H/R treatment, the expressions of apoptosis - related proteins BAD, BAX, and c - CASPASE - 3 increased, while the expression of the anti - apoptotic protein BCL2 decreased.
4. **TRIM27 overexpression alleviates liver injury and the inflammatory response**:
- In liver - specific TRIM27 overexpression (Trim27 - HTG) mice after liver I/R injury, the serum ALT and AST levels decreased significantly, and the necrotic area in liver tissue decreased.
- TRIM27 overexpression inhibited the expression of pro - inflammatory factors, reduced the infiltration of immune cells, and inhibited the activation of the NF - κB signaling pathway.
- In vitro experiments, in hepatocytes with TRIM27 overexpression, after H/R treatment, the inflammatory response was significantly weakened.
5. **TRIM27 alleviates liver I/R injury by inhibiting TAK1 activity**:
- RNA - Seq analysis showed that TRIM27 deficiency mainly affected the MAPK signaling pathway, TNF signaling pathway, and chemokine signaling pathway.
- TRIM27 deficiency led to a significant increase in the phosphorylation level of TAK1, while TRIM27 overexpression inhibited the phosphorylation of TAK1.
- TRIM27 promotes the degradation of TAB2/3 by interacting with its C - terminal coiled - coil and RFP domains, thereby inhibiting the activity of TAK1.
### Conclusion
TRIM27 is a key regulator of liver I/R injury. By mediating the degradation of TAB2/3 and inhibiting the downstream TAK1 - JNK/p38 signaling pathway, it reduces the inflammatory response and apoptosis, thereby protecting the liver from I/R injury. TRIM27 may become a new target for the prevention and treatment of liver I/R injury.